1. Home
  2. IMNM vs MBUU Comparison

IMNM vs MBUU Comparison

Compare IMNM & MBUU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • MBUU
  • Stock Information
  • Founded
  • IMNM 2006
  • MBUU 1982
  • Country
  • IMNM United States
  • MBUU United States
  • Employees
  • IMNM N/A
  • MBUU N/A
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • MBUU Marine Transportation
  • Sector
  • IMNM Health Care
  • MBUU Industrials
  • Exchange
  • IMNM Nasdaq
  • MBUU Nasdaq
  • Market Cap
  • IMNM 806.1M
  • MBUU 699.9M
  • IPO Year
  • IMNM 2020
  • MBUU 2014
  • Fundamental
  • Price
  • IMNM $9.52
  • MBUU $34.51
  • Analyst Decision
  • IMNM Strong Buy
  • MBUU Buy
  • Analyst Count
  • IMNM 5
  • MBUU 7
  • Target Price
  • IMNM $28.60
  • MBUU $42.83
  • AVG Volume (30 Days)
  • IMNM 1.2M
  • MBUU 196.4K
  • Earning Date
  • IMNM 03-27-2025
  • MBUU 01-30-2025
  • Dividend Yield
  • IMNM N/A
  • MBUU N/A
  • EPS Growth
  • IMNM N/A
  • MBUU N/A
  • EPS
  • IMNM N/A
  • MBUU N/A
  • Revenue
  • IMNM $10,129,000.00
  • MBUU $733,991,000.00
  • Revenue This Year
  • IMNM N/A
  • MBUU $0.26
  • Revenue Next Year
  • IMNM N/A
  • MBUU $11.12
  • P/E Ratio
  • IMNM N/A
  • MBUU N/A
  • Revenue Growth
  • IMNM N/A
  • MBUU N/A
  • 52 Week Low
  • IMNM $8.97
  • MBUU $30.20
  • 52 Week High
  • IMNM $30.96
  • MBUU $47.82
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 40.66
  • MBUU 38.61
  • Support Level
  • IMNM $9.67
  • MBUU $36.03
  • Resistance Level
  • IMNM $10.68
  • MBUU $37.99
  • Average True Range (ATR)
  • IMNM 0.80
  • MBUU 1.48
  • MACD
  • IMNM -0.08
  • MBUU -0.26
  • Stochastic Oscillator
  • IMNM 0.34
  • MBUU 4.57

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.

About MBUU Malibu Boats Inc.

Malibu Boats is a leading designer and manufacturer of power boats in the United States. It is the market leader in performance sport boats, sold under its Malibu and Axis brands. It acquired Cobalt Boats, a leading producer of sterndrive boats in the us in the 24- to 29-foot segment, in 2017 and Pursuit Boats, which makes high-end offshore and outboard motorboats, in 2018. In 2021, it purchased Maverick Boat Group, a leading seller of flat fishing boats, including bay, dual-console, and center-console boats. Malibu has also expanded into boat trailers and accessories and in 2020 began producing its own engines (Monsoon) for its performance sport boats and now for Cobalt. Malibu's target market includes a wide range of water enthusiasts who embrace the active outdoor lifestyle.

Share on Social Networks: